Translate the page
Feel free to ask any questions, leave your comments, wishes and suggestions regarding the Google Translation at our Telegram Chat.
Like this video

Milestones CDRX

Trade Equities and Bonds as Securitised Tokens

By converting existing equities and bonds into securitised crypto-tokens (Crypto Depository Receipts – CDRs), CDRX is allowing anyone to invest in financial markets, and buy a piece of any company with as little or as much money as they can afford. Buy an Apple CDR, you have the legal right to an Apple stock, including dividends, voting and all other shareholder rights. Buy 1/50 of an Apple CDR, and receive 1/50 of the rights. Tokenisation allows fractional ownership, lowers costs and shortens transaction times. Each CDR token gives the owner the legal right to the underlying stock or bond, which is held by an independent depository bank/trust on behalf of you, the token owner. CDRX is also building an institutional grade platform that operates 24/7 to allow you to trade both non-securitised tokens (eg. cryptocurrencies and utility tokens) and securitised tokens (eg. CDRs) safely and easily.

4.0
4 expert ratings
3.8
4.0
4.6
3.7
View rating distribution
Ended
Token
CDRX
Type
Price in preICO
1 CDRX = 0.5 USD
Price in ICO
0.5000 USD
Country
Whitelist/KYC
KYC & Whitelist
Restricted areas
USA, China
preICO start
5th Nov 2018
preICO end
19th Nov 2018
ICO start
19th Nov 2018
ICO end
23rd Dec 2018
More on ICO
Report

Milestones

1
01-Feb-18

CDR testing began with a closed set of clients.

2
05-Mar-18

Roadmap for regulator engagement laid out.

3
07-May-18

Development of Exchange started.

4
22-Jun-18

Agreement to use (and right to buy) sharemarket.com for Exchange.

5
15-Jul-18

White paper released to the public.

6
Q4 2018

Audit and penetration testing of Exchange begins (weekly);
Launch of Exchange (ver 0.9) - closed beta;
Indices defined;
Non-securitised market makers onboarded;
Listing service provider agreements signed;
Algo toolkit (ver 0.9 beta) launches.

7
Q1 2019

Release of Exchange (ver 1.0);
Rating agency agreement for new issuance signed;
Launch of industry think tank – tier 1 banks and brokers, business and technology;
Algo toolkit (ver 1.0) released;
CCP agreement signed;
CDR market makers onboarded;
Regulator approvals received (small jurisdictions);
Equity CDRs open to the market in approved jurisdictions;
Exchange trading of CDRs begins among approved investors;
Extension into cash bond CDRs.

8
Q2 2019

Indices launch and licensing (including 6 months of history); Sponsorship of collaborative R&D programme across industry and universities;
Custody service (ver 0.9 beta) launches;
Launch of institutional OTC desk.

9
Q3 2019

Custody service (ver 1.0) released;
Extension into derivative CDRs and native issuance;
Licensing of liquidity to brokers and banks;
Purchase of stake in an authorised and regulated exchange;
Release of decentralised Exchange (ver 2.0), non-securitised .

10
Q4 2019

Regulator approvals received (mid-sized jurisdictions).

11
Q4 2020

Regulator approvals received (large jurisdictions).

12
Q2 2021

Purchase of stake in traditional bank enabling improved ‘real-world’ integration.

Bookmark
ICO KYC Report
2 members invited
David Ward
Passed
Matthew Spittle
Passed
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

Volentix

Volentix is building a decentralized digital assets exchange connected with a secure mu...

7 days 6 hours left

SOMESING

SOMESING is a social music service that incorporates blockchain technology so that prod...

Starts in 7 days 7 hours

Pledgecamp

Pledgecamp is securing the future of crowdfunding with blockchain protected investments.

26 days 6 hours left
4.2

MEDICOHEALTH

Medicohealth Platform will allow for fully anonymous, safe, and efficient communication...

Starts in 54 days 0 hours
Read our Weekly Digest #7Weekly Digest #7

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it